Announcements
- Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024
- Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Pulmonx Reports First Quarter 2024 Financial Results
- Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
- Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
- Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
- Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
- Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
- Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
- Pulmonx to Participate at Upcoming Investor Conferences
More ▼
Key statistics
As of last trade, Pulmonx Corp (4NI:DEU) traded at 7.65, 44.34% above the 52 week low of 5.30 set on Jun 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.60 |
---|---|
High | 7.65 |
Low | 7.55 |
Bid | 7.60 |
Offer | 7.75 |
Previous close | 7.75 |
Average volume | 0.00 |
---|---|
Shares outstanding | 38.82m |
Free float | 36.77m |
P/E (TTM) | -- |
Market cap | 322.17m USD |
EPS (TTM) | -1.54 USD |
Data delayed at least 15 minutes, as of Jul 24 2024.
More ▼